Cargando…

Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis

OBJECTIVES: Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder. Diagnosing AOSD can be challenging, as disease presentation and clinical course are highly heterogeneous. For unclear reasons, a few patients develop life-threatening complications. Our objective was to determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahbi, Anaïs, Tessoulin, Benoît, Bretonnière, Cédric, Boileau, Julien, Carpentier, Dorothée, Decaux, Olivier, Fardet, Laurence, Geri, Guillaume, Godmer, Pascal, Goujard, Cécile, Maisonneuve, Hervé, Mari, Arnaud, Pouchot, Jacques, Ziza, Jean-Marc, Georgin-Lavialle, Sophie, Hamidou, Mohamed, Néel, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504015/
https://www.ncbi.nlm.nih.gov/pubmed/34635157
http://dx.doi.org/10.1186/s13075-021-02631-7
_version_ 1784581244486418432
author Wahbi, Anaïs
Tessoulin, Benoît
Bretonnière, Cédric
Boileau, Julien
Carpentier, Dorothée
Decaux, Olivier
Fardet, Laurence
Geri, Guillaume
Godmer, Pascal
Goujard, Cécile
Maisonneuve, Hervé
Mari, Arnaud
Pouchot, Jacques
Ziza, Jean-Marc
Georgin-Lavialle, Sophie
Hamidou, Mohamed
Néel, Antoine
author_facet Wahbi, Anaïs
Tessoulin, Benoît
Bretonnière, Cédric
Boileau, Julien
Carpentier, Dorothée
Decaux, Olivier
Fardet, Laurence
Geri, Guillaume
Godmer, Pascal
Goujard, Cécile
Maisonneuve, Hervé
Mari, Arnaud
Pouchot, Jacques
Ziza, Jean-Marc
Georgin-Lavialle, Sophie
Hamidou, Mohamed
Néel, Antoine
author_sort Wahbi, Anaïs
collection PubMed
description OBJECTIVES: Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder. Diagnosing AOSD can be challenging, as disease presentation and clinical course are highly heterogeneous. For unclear reasons, a few patients develop life-threatening complications. Our objective was to determine whether these cases resulted from therapeutic delay or could represent a peculiar AOSD subset. METHODS: We conducted a multicentre retrospective study of 20 AOSD patients with organ failure requiring intensive care unit admission and 41 control AOSD patients without organ failure. Clinico-biological data at hospital admission were explored using supervised analyses and unsupervised dimension reduction analysis (factor analysis of mixed data, FAMD). RESULTS: Disease duration before admission was shorter in patients with life-threatening AOSD (median, 10 vs 20 days, p = 0.007). Disease duration before AOSD therapy initiation also tended to be shorter (median, 24 vs 32 days, p = 0.068). Despite this shorter disease duration, FAMD, hierarchical clustering and univariate analyses showed that these patients exhibited distinctive characteristics at first presentation, including younger age; higher frequency of splenomegaly, liver, cardiac and/or lung involvement; less frequent arthralgia; and higher ferritin level. In multivariate analysis, 3 parameters predicted life-threatening complications: lack of arthralgia, younger age and shorter time between fever onset and hospitalisation. CONCLUSION: This study suggests that life-threatening complications of AOSD occur very early, in a peculiar subset, which we propose to name catastrophic adult-onset Still’s disease (CAOSD). Its exact burden may be underestimated and remains to be clarified through large multicentre cohorts. Further studies are needed to identify red flags and define the optimal therapeutic strategy.
format Online
Article
Text
id pubmed-8504015
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85040152021-10-20 Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis Wahbi, Anaïs Tessoulin, Benoît Bretonnière, Cédric Boileau, Julien Carpentier, Dorothée Decaux, Olivier Fardet, Laurence Geri, Guillaume Godmer, Pascal Goujard, Cécile Maisonneuve, Hervé Mari, Arnaud Pouchot, Jacques Ziza, Jean-Marc Georgin-Lavialle, Sophie Hamidou, Mohamed Néel, Antoine Arthritis Res Ther Research Article OBJECTIVES: Adult-onset Still’s disease (AOSD) is a rare systemic inflammatory disorder. Diagnosing AOSD can be challenging, as disease presentation and clinical course are highly heterogeneous. For unclear reasons, a few patients develop life-threatening complications. Our objective was to determine whether these cases resulted from therapeutic delay or could represent a peculiar AOSD subset. METHODS: We conducted a multicentre retrospective study of 20 AOSD patients with organ failure requiring intensive care unit admission and 41 control AOSD patients without organ failure. Clinico-biological data at hospital admission were explored using supervised analyses and unsupervised dimension reduction analysis (factor analysis of mixed data, FAMD). RESULTS: Disease duration before admission was shorter in patients with life-threatening AOSD (median, 10 vs 20 days, p = 0.007). Disease duration before AOSD therapy initiation also tended to be shorter (median, 24 vs 32 days, p = 0.068). Despite this shorter disease duration, FAMD, hierarchical clustering and univariate analyses showed that these patients exhibited distinctive characteristics at first presentation, including younger age; higher frequency of splenomegaly, liver, cardiac and/or lung involvement; less frequent arthralgia; and higher ferritin level. In multivariate analysis, 3 parameters predicted life-threatening complications: lack of arthralgia, younger age and shorter time between fever onset and hospitalisation. CONCLUSION: This study suggests that life-threatening complications of AOSD occur very early, in a peculiar subset, which we propose to name catastrophic adult-onset Still’s disease (CAOSD). Its exact burden may be underestimated and remains to be clarified through large multicentre cohorts. Further studies are needed to identify red flags and define the optimal therapeutic strategy. BioMed Central 2021-10-11 2021 /pmc/articles/PMC8504015/ /pubmed/34635157 http://dx.doi.org/10.1186/s13075-021-02631-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Wahbi, Anaïs
Tessoulin, Benoît
Bretonnière, Cédric
Boileau, Julien
Carpentier, Dorothée
Decaux, Olivier
Fardet, Laurence
Geri, Guillaume
Godmer, Pascal
Goujard, Cécile
Maisonneuve, Hervé
Mari, Arnaud
Pouchot, Jacques
Ziza, Jean-Marc
Georgin-Lavialle, Sophie
Hamidou, Mohamed
Néel, Antoine
Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis
title Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis
title_full Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis
title_fullStr Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis
title_full_unstemmed Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis
title_short Catastrophic adult-onset Still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis
title_sort catastrophic adult-onset still’s disease as a distinct life-threatening clinical subset: case–control study with dimension reduction analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504015/
https://www.ncbi.nlm.nih.gov/pubmed/34635157
http://dx.doi.org/10.1186/s13075-021-02631-7
work_keys_str_mv AT wahbianais catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT tessoulinbenoit catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT bretonnierecedric catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT boileaujulien catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT carpentierdorothee catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT decauxolivier catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT fardetlaurence catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT geriguillaume catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT godmerpascal catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT goujardcecile catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT maisonneuveherve catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT mariarnaud catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT pouchotjacques catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT zizajeanmarc catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT georginlaviallesophie catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT hamidoumohamed catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis
AT neelantoine catastrophicadultonsetstillsdiseaseasadistinctlifethreateningclinicalsubsetcasecontrolstudywithdimensionreductionanalysis